120 companies
CompanyLast Price7D Return1Y ReturnMarket CapAnalysts TargetValuationGrowthDiv Yield

6634

Sinew Pharma
NT$65.10-2.7%-24.2%NT$4.6bn/aPB3.3xn/an/a

4120

Orient EuroPharma
NT$42.201.4%18.9%NT$3.7bn/aPE25.4xn/a2.4%

4172

InnoPharmax
NT$15.35-4.1%-9.2%NT$1.5bn/aPS29.7xn/an/a

6891

Locus Cell
NT$22.30-8.0%-53.3%NT$4.5bn/aPB2.4xn/an/a

4726

Mycenax Biotech
NT$37.60-2.3%-2.3%NT$7.7bn/aPS11.9xn/an/a

4142

Adimmune
NT$26.70-6.5%-31.9%NT$11.2bn/aPS6.2xn/a0%

6645

Kim Forest Enterprise
NT$39.40-7.8%21.5%NT$2.0bn/aPS4.8xn/a0.2%

6794

UnicoCell Biomed
NT$88.500.7%15.4%NT$4.9bn/aPS200.4xn/an/a

4192

SynCore BiotechnologyLtd
NT$37.002.1%-51.3%NT$1.3bn/aPS68.1xn/an/a

6535

Lumosa Therapeutics
NT$169.00-2.3%313.7%NT$27.9bn/aPS528xn/an/a

6580

TaiRx
NT$24.45-1.6%-30.0%NT$2.2bn/aPS348.3xn/an/a

4132

Golden Biotechnology
NT$37.60-3.8%-23.3%NT$5.3bn/aPS28.8xn/an/a

6564

Enimmune
NT$33.65-8.9%-34.5%NT$2.2bn/aPS50.9xn/an/a

6661

Welgene BiotechLtd
NT$22.65-2.8%-1.1%NT$527.8mn/aPS1.9xn/a0.8%

4195

Genomics BioSci & Tech.Ltd
NT$18.90-2.1%-7.5%NT$1.4bn/aPS3.4xn/a0.5%

4117

General Biologicals
NT$22.10-0.7%-17.8%NT$1.3bn/aPS4.8xn/an/a

6935

Prince Pharmaceutical
NT$32.95-1.8%n/aNT$1.2bn/aPE50xn/an/a

6932

Mercury Biopharmaceutical
NT$15.95-5.9%-36.2%NT$6.6bn/aPS2475.6xn/an/a

6547

Medigen Vaccine Biologics
NT$54.00-3.1%-6.7%NT$17.7bNT$133.00PS45.5xn/an/a

6704

Gwo Xi Stem Cell Applied Technology
NT$29.70-1.7%n/aNT$2.8bn/aPS17.8xn/an/a

6709

Advagene Biopharma
NT$20.200.5%-30.3%NT$1.1bn/aPB12.7xn/an/a

4123

Center Laboratories
NT$42.65-4.8%4.2%NT$29.5bn/aPS24xn/a2.1%

4166

Orient Pharma
NT$20.10-2.0%-14.5%NT$4.5bn/aPS7xn/an/a

6549

TaiwanJ Pharmaceuticals
NT$13.95-0.4%-59.3%NT$1.0bn/aPS68.2xn/an/a
Page 4 of 5
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.